Re-challenge [177Lu]Lu-PSMA-617 in patients with advanced prostate cancer: outcome and safety

被引:0
|
作者
Yordanova, Anna [2 ]
Essler, Markus [2 ]
Hauser, Stefan [3 ]
Feldmann, Georg [1 ]
Ahmadzadehfar, Hojjat [2 ]
机构
[1] MED3 Univ Hosp Bonn, Dept Internal Med 3, Bonn, Germany
[2] Univ Hosp Bonn, Dept Nucl Med, Bonn, Germany
[3] Univ Hosp Bonn, Dept Urol, Bonn, Germany
关键词
D O I
暂无
中图分类号
R8 [特种医学]; R445 [影像诊断学];
学科分类号
1002 ; 100207 ; 1009 ;
摘要
526
引用
收藏
页数:1
相关论文
共 50 条
  • [1] Outcome and safety of rechallenge [177Lu]Lu-PSMA-617 in patients with metastatic prostate cancer
    Anna Yordanova
    Paula Linden
    Stefan Hauser
    Michael Meisenheimer
    Stefan Kürpig
    Georg Feldmann
    Florian C. Gaertner
    Markus Essler
    Hojjat Ahmadzadehfar
    [J]. European Journal of Nuclear Medicine and Molecular Imaging, 2019, 46 : 1073 - 1080
  • [2] Outcome and safety of rechallenge [177Lu]Lu-PSMA-617 in patients with metastatic prostate cancer
    Yordanova, Anna
    Linden, Paula
    Hauser, Stefan
    Meisenheimer, Michael
    Kuerpig, Stefan
    Feldmann, Georg
    Gaertner, Florian C.
    Essler, Markus
    Ahmadzadehfar, Hojjat
    [J]. EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING, 2019, 46 (05) : 1073 - 1080
  • [3] Urinary excretion kinetics of [177Lu]Lu-PSMA-617
    de Bakker, Maarten
    Dominicus, Noa
    Meeuwis, Antoi
    Janssen, Marcel
    Konijnenberg, Mark W. W.
    Nagarajah, James
    Peters, Steffie M. B.
    [J]. EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING, 2023, 50 (12) : 3572 - 3575
  • [4] Urinary excretion kinetics of [177Lu]Lu-PSMA-617
    Maarten de Bakker
    Noa Dominicus
    Antoi Meeuwis
    Marcel Janssen
    Mark W. Konijnenberg
    James Nagarajah
    Steffie M. B. Peters
    [J]. European Journal of Nuclear Medicine and Molecular Imaging, 2023, 50 : 3572 - 3575
  • [5] Prognostic Tumor Markers In Men With Prostate Cancer Undergoing [177Lu]Lu-PSMA-617
    Yordanova, A.
    Linden, P.
    Hauser, S.
    Feldmann, G.
    Fimmers, R.
    Essler, M.
    Holdenrieder, S.
    Ahmadzadehfar, H.
    [J]. EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING, 2019, 46 (SUPPL 1) : S237 - S237
  • [6] Castration-resistant prostate cancer: [177Lu]Lu-PSMA-617 versus cabazitaxel Comment
    Todenhoefer, Tilman
    [J]. AKTUELLE UROLOGIE, 2023, 54 (04)
  • [7] Combining enzalutamide and [177Lu]Lu-PSMA-617 in metastatic castration-resistant prostate cancer
    Houede, Nadine
    Hebert, Kevin
    [J]. LANCET ONCOLOGY, 2024, 25 (05): : 531 - 533
  • [8] PSMA PET total tumor volume predicts outcome of patients with advanced prostate cancer receiving [177Lu]Lu-PSMA-617 radioligand therapy in a bicentric analysis
    Seifert, Robert
    Kessel, Katharina
    Schlack, Katrin
    Weber, Manuel
    Herrmann, Ken
    Spanke, Maximilian
    Fendler, Wolfgang P.
    Hadaschik, Boris
    Kleesiek, Jens
    Schaefers, Michael
    Weckesser, Matthias
    Boegemann, Martin
    Rahbar, Kambiz
    [J]. EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING, 2021, 48 (04) : 1200 - 1210
  • [9] Matched-pair analysis of [177Lu]Lu-PSMA I&T and [177Lu]Lu-PSMA-617 in patients with metastatic castration-resistant prostate cancer
    Philipp E. Hartrampf
    Franz-Xaver Weinzierl
    Andreas K. Buck
    Steven P. Rowe
    Takahiro Higuchi
    Anna Katharina Seitz
    Hubert Kübler
    Andreas Schirbel
    Markus Essler
    Ralph A. Bundschuh
    Rudolf A. Werner
    [J]. European Journal of Nuclear Medicine and Molecular Imaging, 2022, 49 : 3269 - 3276
  • [10] PSMA PET total tumor volume predicts outcome of patients with advanced prostate cancer receiving [177Lu]Lu-PSMA-617 radioligand therapy in a bicentric analysis
    Robert Seifert
    Katharina Kessel
    Katrin Schlack
    Manuel Weber
    Ken Herrmann
    Maximilian Spanke
    Wolfgang P. Fendler
    Boris Hadaschik
    Jens Kleesiek
    Michael Schäfers
    Matthias Weckesser
    Martin Boegemann
    Kambiz Rahbar
    [J]. European Journal of Nuclear Medicine and Molecular Imaging, 2021, 48 : 1200 - 1210